Insperity (NSP)
(Delayed Data from NYSE)
$92.98 USD
-1.80 (-1.90%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $93.06 +0.08 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$92.98 USD
-1.80 (-1.90%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $93.06 +0.08 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
CoreLogic (CLGX) Touches 52-Week High: What's Driving It?
by Zacks Equity Research
CoreLogic (CLGX) has been benefiting from consistent better-than-expected earnings and revenue performance, shareholder friendly moves and contributions from acquisitions.
Boxlight (BOXL) Names Mark Starkey as Its New President
by Zacks Equity Research
As president, Starkey is set to provide leadership to Boxlight's (BOXL) global sales and work across functions and operations.
Equifax (EFX) Launches a New Mortgage Verification Solution
by Zacks Equity Research
Equifax's (EFX) Mortgage Duo is developed at par with the growing need for hassle-free digital lending experience.
Rollins (ROL) Up 73.9% Year to Date: What's Behind the Rally?
by Zacks Equity Research
Rollins' (ROL) stock has been benefiting from consecutive better-than-expected top-line performance and contributions from acquisitions.
Accenture (ACN) Adds TripleBlind to Its Investment Portfolio
by Zacks Equity Research
Accenture (ACN) and TripleBlind will co-innovate in Accenture's Innovation Hubs, Labs and Liquid Studios.
Why You Should Hold CoreLogic (CLGX) Stock in Your Portfolio
by Zacks Equity Research
CoreLogic (CLGX) benefits from operational capabilities, data and technology platforms as well as acquisitions. However, high debt is a concern.
S&P Global's (SPGI) Division Unveils Energy Transition Dataset
by Zacks Equity Research
S&P Global's (SPGI) new energy transition dataset is aimed at equipping market participants with enhanced forecasting and analysis.
Why Booz Allen (BAH) Stock Should be in Your Portfolio?
by Zacks Equity Research
Booz Allen (BAH) is focusing on areas such as artificial intelligence, advanced engineering, directed energy and modern digital platforms to drive innovation.
Equifax (EFX) Selects Bourgeois as Automotive General Manager
by Zacks Equity Research
Bourgeois will be responsible for strengthening Equifax's (EFX) foothold in the automotive market.
FLEETCOR (FLT) Adds a New Member to Board of Directors
by Zacks Equity Research
FLEETCOR (FLT) welcomes Archie L. Jones, Jr. to its board of directors.
Accenture (ACN) Closes Avenai Buyout, Boosts Canada Footprint
by Zacks Equity Research
The acquisition enhances Accenture's (ACN) technology-transformation capabilities across the public-sector market in Canada.
Verisk Analytics (VRSK) Stock Up 33.8% YTD: What's Behind It?
by Zacks Equity Research
Better-than-expected top-line performance, organic growth and contributions from acquisitions have been benefiting Verisk (VRSK) stock.
S&P Global (SPGI) Stock Rises 22.7% Year to Date: Here's Why
by Zacks Equity Research
Encouraging 2020 EPS guidance, consecutive better-than-expected top- and bottom-line performances and contributions from acquisitions have been aiding S&P Global (SPGI).
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Consecutive better-than-expected top- and bottom-line performances, encouraging yearly guidance and shareholder friendly moves have been aiding IQVIA Holdings (IQV) stock.
3 Stocks to Benefit From the Steady Growth in Jobs
by Zacks Equity Research
Steadily rising U.S. jobs and falling unemployment make it judicious to invest in staffing firms like Insperity (NSP) and Cross Country Healthcare (CCRN).
Republic Services (RSG) Stock Up 12.9% in a Year: Here's Why
by Zacks Equity Research
Consecutive better-than-expected bottom-line performances, encouraging cash flow guidance and shareholder friendly moves have been aiding Republic Services' stock
Zacks.com featured highlights include: ResMed, Microsoft, Activision Blizzard, Best Buy and Insperity
by Zacks Equity Research
Zacks.com featured highlights include: ResMed, Microsoft, Activision Blizzard, Best Buy and Insperity
5 Great Dividend Growth Stocks to Keep Volatility at Bay
by Sweta Killa
Dividend growth strategy is a major source of consistent income for investors in any type of market, though it doesn't offer dramatic price appreciation.
Insperity (NSP) Q3 Earnings Beat Estimates, Stock Up 2.5%
by Zacks Equity Research
Insperity's (NSP) third-quarter 2020 results reflect outperformance in worksite employee growth and pricing.
Insperity's (NSP) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Insperity (NSP).
Zacks Industry Outlook Highlights: Robert Half International, Insperity and Kforce
by Zacks Equity Research
Zacks Industry Outlook Highlights: Robert Half International, Insperity and Kforce
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
by Zacks Equity Research
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
Pick These 5 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Meritage Homes (MTH), Vertex Pharmaceuticals (VRTX), CVS Health (CVS), Amedisys (AMED) and Insperity (NSP) are sound enough to meet financial obligations.
3 Stocks From the Promising Staffing Space to Watch Out For
by Sanjana Goswami
The coronavirus-driven dependency on technology, abrupt shift in recruitment patterns within the industry and reduction in expenses should help the Zacks Staffing industry thrive. RHI, NSP and KFRC are well positioned to witness demand surge.
Staffing Industry Up 30.4% in Past 6 Months: Stocks in Focus
by Sanjana Goswami
Coronavirus-induced strict lockdowns and market uncertainties lead to an abrupt shift in recruitment patterns within the staffing industry.